The Cannigma

JANUARY 13, 2023

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. A primary headache, such as a migraine, is its own condition, and not caused by a separate condition.

Terpenes 132

Terpenes Strains THC Treatment 132

The Cannigma

MAY 19, 2021

Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. That could potentially change in the near future, however.

Law 137

Law Legalization Clinical Trials CBD 137

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. A doctor who applies to the TGA on behalf of a patient must provide a clinical justification.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Project CBD

OCTOBER 26, 2023

United Kingdom-based GW Pharmaceuticals has produced the world’s first approved cannabis-based medicines for the UK, US, and European markets, Sativex® and Epidiolex®. As part of the approval process for all markets, they have conducted critical Phase 2 studies on various conditions, including cancer.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Cannabis Law Report

JULY 25, 2022

Psychedelics, medicine and ethics has always been a tricky thing and we’re suprised (or maybe not) that those who have held themselves up to be the paragons of perfection in the field over the past few years, have in fact been either arrogant, dumb or lazy when it comes to managing ethics at their organisations.

Medicine 52

Medicine Therapy Research and Development Business 52

Cannabis Law Report

OCTOBER 26, 2019

Devices that are used to administer medicines, for example a transdermal patch containing medicine, are regulated as a medicine rather than a medical device. The TGA provides guidance on the appropriate classification of products that are on the device-medicine boundary. One such circumstance is a clinical trial.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

SEPTEMBER 1, 2019

The long-promised, glittering ambitions of a large-scale medicinal cannabis industry in South Australia are about to be tested, with plans to create more than 1000 jobs at a major new manufacturing facility in Adelaide. reports In Daily and independent news source based in the city. Fitzsimons seized the opportunity.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Cannabis Law Report

MAY 29, 2022

In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] 4] In April 2021, a separate study from the New England Journal of Medicine demonstrated the efficacy of psilocybin in reducing symptoms of depression. [5] Clinical Trials and Human Subject Protections.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 9, 2021

In a typical scenario, psychedelic substances would be used in conjunction with psychotherapy sessions to treat disorders for which other medicinal therapies have failed. Beginning in 2018, the FDA has started to grant special designations to study the medicinal use of psilocybin via Breakthrough Therapy status. Id ; 21 CFR 312.1-10;

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

DECEMBER 14, 2019

Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. Here’s the spruik…… Since then, Australia’s medicinal marijuana industry has been hit by the slump currently dragging down marijuana markets across the world.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

SpeedWeed

AUGUST 4, 2021

After watching my brother self-medicate for his chronic pain for decades, I didn’t understand how cannabis was important to him as a medicine. in 2014, I watched my brother walk into a cannabis clinic. It had a dispensary out the front, and the doctors prescribing the medicines were out the back. During a social trip to the U.S.

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. Legalisation occurred in Australia in 2016.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. North America Legal Cannabis Number of clinical trials. Hemp Market Estimates and Forecasts, 2016-2028 (USD Million).

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

MARCH 21, 2019

However, CBD will provide many medicinal benefits including reducing inflammation, pain, anxiety, stress, migraines, seizures, depression, and the ability to obtain a much deeper sleep so you can wake up well rested and ready to tackle your daily tasks. You can find the list of medical conditions here.

State Laws 55

State Laws Law CBD Legalization 55

Greencamp

FEBRUARY 2, 2019

Examples include pneumonia, cancers, tuberculosis, chronic diarrhea, and inflammation-based conditions such as meningitis and encephalitis. Depending on what type of cell it is, but also the type of condition a person is struggling with, these factors determine the way how will a specific cell react to cannabinoids. 2016 ( 3 ).

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

APRIL 10, 2019

In November, UK law changed to allow clinicians to prescribe medical cannabis under limited conditions. He added, “I welcome the trials and I welcome the review, but, sadly, people need these medicines now. In relation to childhood epilepsy, the British Paediatric Neurology Association has issued interim clinical guidance.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

CannaMD

NOVEMBER 6, 2019

Results further indicate that the presence of medicinal cannabis legislation appears to have no influence over opioid misuse. This led to the conclusion that: Medical marijuana laws may ultimately serve to attenuate the consequences of opioid over reliance. million to 11.4

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JUNE 4, 2021

Although psychedelics have been used by humans for over 7,000 years across multiple different cultures, only in the past century have these medicines been outlawed by governments around the world. Fortunately, the past several years have seen a resurgence in awareness and interest in psychedelic medicine. in/timferriss/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

The Cannigma

APRIL 8, 2021

Listen & Subscribe: As both a regulated medicine and something people use for wellness and even recreation, the information gaps that exist for cannabis users are unprecedented. Any other medication and you’re lawfully entitled to speak to a pharmacist,” explains Dr. Codi Peterson, a clinical pharmacist and medical cannabis professional.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. These plant cannabinoids were also deemed useful for treating other neurodegenerative conditions, “such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

JUNE 30, 2019

Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. However, the Governor is expected to veto a bill that would allow inter-island transfer of medicinal cannabis.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

JUNE 11, 2019

The accident also reactivated a pre-existing psychological condition which manifested as a chronic pain syndrome, and a pre-existing depressive disorder which was in partial remission at the time of trial. While Carrillo sought $91,032 for the future costs of medicinal cannabis, the court awarded $12,000. White , 2016 BCSC 569.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45